Blood Cancer Cases in Young Age: At one time, the elders were considered to be the risk of cancer, but these young people are suffering from these fatal diseases. You will be surprised to learn that between 3000 young patients is coming in front of the Michel Mloyed Lugmia (AML) in the capital Delhi. AML is an aggressive blood cancer, which may have died at times. Doctors say this disease now is a serious crisis that is increasing rapid crisis in the age of 30 to 40 years old. Awareness of this disease is essential.
According to a report of TOI, the growing cases of blood cancer are worried, but also a horrible patient suffers from only 30% of the AML cancer complement their treatment. This is the lack of expensive treatment and facilities. According to the doctors, India is neither a fairly awareness of cancer, nor are easy treatment facilities. This is why it is very challenging to identify and treat this type of cancer and treating. Due to this many young people losing their lives.
Additional Professor of the Department of AIIMS’s medical oncology. According to Ranjit Kumar Sahu, the symptoms of AML cancer are very common, which causes people unable to recognize it. In fact, when this blood suffers from cancer, young people appear in fatigue or infection, which causes cancer late and cancer. This cancer can be identified with a simple blood test, but the treatment is very expensive where the patient has to go to a third rank center for treatment. If this cancer does not know at the right time, it reaches an advanced stage and decreases the possibility of treatment.
Experts believe that people who have faced chemotherapy or radiation more. In such patients, this cancer can emerge as a secondary dangerous. Patients are divided into ‘fit’ and ‘unfit’ in the basis of their situation. The ‘fit’ patients need a stem cell transplant, which is possible in about 50% of cases.
The Vice-Chairman of the BLK Super Specialty Hospital and Vice Chairman of the BMT Department. According to Chaudhary, the city like Delhi is also lacking the integrated treatment system for this serious disease. There is no standard diagnostic process for AML in government hospitals. As a result, the patient’s condition deteriorations before you start treatment. To save lives from this cancer, the availability of the time of symptoms, genetic testing and targeted therapy is very important.
In the world, genetic testing and targeted medications have improved AML treatment, but these facilities in India are still limited. Targeted drugs are expensive and not included in national health plans or cancerous drug registry. As for this 15-20% of the patient die in the first 30 days of starting treatment. Experts believe if patients start treatment without infection, they are likely to survive. Therefore, India will have to develop a better and accessible treatment system as soon as possible.